Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
Condition(s):Mycosis FungoidesLast Updated:October 31, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Mycosis FungoidesLast Updated:October 31, 2012Completed
Condition(s):Mycosis FungoidesLast Updated:August 9, 2012Completed
Condition(s):Hodgkin’s LymphomaLast Updated:September 22, 2023Completed
Condition(s):Mycosis Fungoides of Skin (Diagnosis); Cutaneous T-cell Lymphoma; Non Hodgkin Lymphoma; Lymphomatoid Papulosis; Lymphoma, Large-Cell, Anaplastic; Lymphoma, FollicularLast Updated:December 19, 2023Not yet recruiting
Condition(s):Unilateral RetinoblastomaLast Updated:October 13, 2023Completed
Condition(s):Hepatocellular CarcinomaLast Updated:August 23, 2013Terminated
Condition(s):DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell MyelomaLast Updated:September 1, 2020Completed
Condition(s):Pancreatic Adenocarcinoma Metastatic; BRCA1 Mutation; BRCA2 Mutation; Pancreatic Acinar Cell Carcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer; Metastatic Pancreatic Cancer; Metastatic Pancreatic Ductal Adenocarcinoma; Breast Cancer Metastatic; Breast Cancer Stage IV; Pancreatic Cancer Stage IV; HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma; Adenocarcinoma of the Breast; PALB2 Gene MutationLast Updated:April 25, 2023Recruiting
Condition(s):Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia; Acute Myeloid Leukemia in Remission; Hematopoietic Cell Transplantation Recipient; Minimal Residual Disease; Myelodysplastic Syndrome; Secondary Acute Myeloid LeukemiaLast Updated:February 22, 2024Recruiting
Condition(s):Plasma Cell Myeloma; Secondary AmyloidosisLast Updated:August 16, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.